Incidence of brain metastasis in patients with esophageal carcinoma

Ron S. Smith, Robert C. Miller

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

AIM: To determine the incidence of brain metastasis in a contemporary group of patients with carcinoma of the esophagus. METHODS: Retrospective analysis of 53 patients with esophageal carcinoma who received radiotherapy as a component of treatment between 1998 and 2007, including patient and tumor characteristics, and subsequent diagnosis of brain metastasis. The association between the histological type of esophageal cancer and the incidence of brain metastasis was assessed using Fisher's exact test. RESULTS: Forty-four of the fifty-three patients in this study had adenocarcinoma and nine had squamous cell carcinoma, ranging from stage IIA-IVB. Primary treatment was surgery with neoadjuvant chemoradiotherapy (trimodality therapy) in 19% of patients; chemoradiotherapy in 42%; and surgery and adjuvant radiotherapy in 7%. Twenty-five percent of patients in this study received palliative radiotherapy. The overall incidence of brain metastasis in this cohort was 13%. Adenocarcinoma was the primary tumor histology in all of the patients who developed brain metastasis, representing an incidence of 16% in this subgroup. No patients with squamous cell carcinoma received trimodality therapy. The association between histology and brain metastasis was not statistically significant. CONCLUSION: The incidence of brain metastasis in this contemporary cohort of patients with esophageal carcinoma is higher than previously reported and was confined to those with adenocarcinoma.

Original languageEnglish (US)
Pages (from-to)2407-2410
Number of pages4
JournalWorld Journal of Gastroenterology
Volume17
Issue number19
DOIs
StatePublished - May 21 2011

Fingerprint

Neoplasm Metastasis
Carcinoma
Incidence
Brain
Adenocarcinoma
Chemoradiotherapy
Squamous Cell Carcinoma
Histology
Radiotherapy
Adjuvant Radiotherapy
Therapeutics
Esophageal Neoplasms
Brain Neoplasms
Esophagus
Neoplasms

Keywords

  • Brain metastasis
  • Esophageal carcinoma

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Incidence of brain metastasis in patients with esophageal carcinoma. / Smith, Ron S.; Miller, Robert C.

In: World Journal of Gastroenterology, Vol. 17, No. 19, 21.05.2011, p. 2407-2410.

Research output: Contribution to journalArticle

Smith, Ron S. ; Miller, Robert C. / Incidence of brain metastasis in patients with esophageal carcinoma. In: World Journal of Gastroenterology. 2011 ; Vol. 17, No. 19. pp. 2407-2410.
@article{912a5180bd38428c90858274cc710628,
title = "Incidence of brain metastasis in patients with esophageal carcinoma",
abstract = "AIM: To determine the incidence of brain metastasis in a contemporary group of patients with carcinoma of the esophagus. METHODS: Retrospective analysis of 53 patients with esophageal carcinoma who received radiotherapy as a component of treatment between 1998 and 2007, including patient and tumor characteristics, and subsequent diagnosis of brain metastasis. The association between the histological type of esophageal cancer and the incidence of brain metastasis was assessed using Fisher's exact test. RESULTS: Forty-four of the fifty-three patients in this study had adenocarcinoma and nine had squamous cell carcinoma, ranging from stage IIA-IVB. Primary treatment was surgery with neoadjuvant chemoradiotherapy (trimodality therapy) in 19{\%} of patients; chemoradiotherapy in 42{\%}; and surgery and adjuvant radiotherapy in 7{\%}. Twenty-five percent of patients in this study received palliative radiotherapy. The overall incidence of brain metastasis in this cohort was 13{\%}. Adenocarcinoma was the primary tumor histology in all of the patients who developed brain metastasis, representing an incidence of 16{\%} in this subgroup. No patients with squamous cell carcinoma received trimodality therapy. The association between histology and brain metastasis was not statistically significant. CONCLUSION: The incidence of brain metastasis in this contemporary cohort of patients with esophageal carcinoma is higher than previously reported and was confined to those with adenocarcinoma.",
keywords = "Brain metastasis, Esophageal carcinoma",
author = "Smith, {Ron S.} and Miller, {Robert C.}",
year = "2011",
month = "5",
day = "21",
doi = "10.3748/wjg.v17.i19.2407",
language = "English (US)",
volume = "17",
pages = "2407--2410",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "19",

}

TY - JOUR

T1 - Incidence of brain metastasis in patients with esophageal carcinoma

AU - Smith, Ron S.

AU - Miller, Robert C.

PY - 2011/5/21

Y1 - 2011/5/21

N2 - AIM: To determine the incidence of brain metastasis in a contemporary group of patients with carcinoma of the esophagus. METHODS: Retrospective analysis of 53 patients with esophageal carcinoma who received radiotherapy as a component of treatment between 1998 and 2007, including patient and tumor characteristics, and subsequent diagnosis of brain metastasis. The association between the histological type of esophageal cancer and the incidence of brain metastasis was assessed using Fisher's exact test. RESULTS: Forty-four of the fifty-three patients in this study had adenocarcinoma and nine had squamous cell carcinoma, ranging from stage IIA-IVB. Primary treatment was surgery with neoadjuvant chemoradiotherapy (trimodality therapy) in 19% of patients; chemoradiotherapy in 42%; and surgery and adjuvant radiotherapy in 7%. Twenty-five percent of patients in this study received palliative radiotherapy. The overall incidence of brain metastasis in this cohort was 13%. Adenocarcinoma was the primary tumor histology in all of the patients who developed brain metastasis, representing an incidence of 16% in this subgroup. No patients with squamous cell carcinoma received trimodality therapy. The association between histology and brain metastasis was not statistically significant. CONCLUSION: The incidence of brain metastasis in this contemporary cohort of patients with esophageal carcinoma is higher than previously reported and was confined to those with adenocarcinoma.

AB - AIM: To determine the incidence of brain metastasis in a contemporary group of patients with carcinoma of the esophagus. METHODS: Retrospective analysis of 53 patients with esophageal carcinoma who received radiotherapy as a component of treatment between 1998 and 2007, including patient and tumor characteristics, and subsequent diagnosis of brain metastasis. The association between the histological type of esophageal cancer and the incidence of brain metastasis was assessed using Fisher's exact test. RESULTS: Forty-four of the fifty-three patients in this study had adenocarcinoma and nine had squamous cell carcinoma, ranging from stage IIA-IVB. Primary treatment was surgery with neoadjuvant chemoradiotherapy (trimodality therapy) in 19% of patients; chemoradiotherapy in 42%; and surgery and adjuvant radiotherapy in 7%. Twenty-five percent of patients in this study received palliative radiotherapy. The overall incidence of brain metastasis in this cohort was 13%. Adenocarcinoma was the primary tumor histology in all of the patients who developed brain metastasis, representing an incidence of 16% in this subgroup. No patients with squamous cell carcinoma received trimodality therapy. The association between histology and brain metastasis was not statistically significant. CONCLUSION: The incidence of brain metastasis in this contemporary cohort of patients with esophageal carcinoma is higher than previously reported and was confined to those with adenocarcinoma.

KW - Brain metastasis

KW - Esophageal carcinoma

UR - http://www.scopus.com/inward/record.url?scp=79957860967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957860967&partnerID=8YFLogxK

U2 - 10.3748/wjg.v17.i19.2407

DO - 10.3748/wjg.v17.i19.2407

M3 - Article

VL - 17

SP - 2407

EP - 2410

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 19

ER -